Despite the deficiency in the cGAS receptor, the injection of WGP (a commercially available S. cerevisiae glucan) or the in-house extract of glucan inhibited the growth of subcutaneous tumors in cGAS-/- mice suggested that non-cGAS-mediated anti-cancer mechanisms are associated with beta-glucan. Here, CGAS is linked to cancer.